Phase II Study of Consolidation Chemotherapy After Concurrent Chemoradiation in Cervical Cancer: Preliminary Results

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 817-822

  Choi, Chel Hun ^a   Lee, Jeong Won ^a   Kim, Tae Joong ^a   Kim, Woo Young ^a   Nam, Hee Rim ^a   Kim, Byoung Gie ^a   Huh, Seung Jae ^a   Lee, Je Ho ^a   Bae, Duk Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cervical carcinoma; Concurrent chemoradiation; Consolidation chemotherapy; High dose rate brachytherapy

Indexed keywords

DRUG DOSAGE; ONCOLOGY; PATIENT TREATMENT; TUMORS;

CERVICAL CARCINOMA; CONCURRENT CHEMORADIATION; CONSOLIDATION CHEMOTHERAPY; HIGH DOSE RATE BRACHYTHERAPY;

CHEMOTHERAPY;

CISPLATIN; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SKIN TOXICITY; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMORBIDITY; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; KOREA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIATION INJURIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 34249337420     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.038     Document Type: Article

References (26)

1. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 (1999) 33-64
2. Perez C.A. Radiation therapy in the management of cancer of the cervix. Oncology 7 (1993) 89-96
3. Jampolis S., Andras E.J., and Fletcher G.H. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology 115 (1975) 681-685
4. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 20 (1991) 667-676
5. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
6. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
7. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecol Oncol Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
8. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
9. Wong L.C., Choo Y.C., Choy D., et al. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 35 (1989) 159-163
10. Vrdoljak E., Prskalo T., Omrcen T., et al. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study. Int J Radiat Oncol Biol Phys 61 (2005) 824-829
11. Huh S.J., Lim D.H., Ahn Y.C., et al. Effect of customized small bowel displacement system in pelvic irradiation. Int J Radiat Oncol Biol Phys 40 (1998) 623-627
12. International Commission on Radiation Units and Measurements Report 38. Dose and Volume Specifications for Reporting Intracavitary Therapy in Gynecology (1985), International Commission in Radiation Units and Measurements, Bethesda MD
13. Choi C.H., Kim T.J., Lee S.J., et al. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix. Int J Gynecol Cancer 16 (2006) 1157-1164
14. Wong L.C., Ngan H.Y., Cheung A.N., et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 17 (1999) 2055-2060
15. Chung Y.L., Jian J.J., Cheng S.H., et al. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: A phase I/II study. Gynecol Oncol 97 (2005) 126-135
16. Lorvidhaya V., Chitapanarux I., Sangruchi S., et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1226-1232
17. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
18. Candelaria M., Chanona-Vilchis J., Cetina L., et al. Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol 3 (2006) 3
19. Mancuso S., Smaniotto D., Benedetti Panici P., et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78 (2000) 324-328
20. Flueckiger F., Ebner F., Poschauko H., et al. Cervical cancer: Serial MR imaging before and after primary radiation therapy-A 2-year follow-up study. Radiology 184 (1992) 89-93
21. Hatano K., Sekiya Y., Araki H., et al. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 45 (1999) 639-644
22. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev (2005) CD002225
23. Lertsanguansinchai P., Lertbutsayanukul C., Shotelersuk K., et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1424-1431
24. Petereit D.G., Sarkaria J.N., Potter D.M., et al. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence-the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 45 (1999) 1267-1274
25. Shakespeare T.P., Lim K.H., Lee K.M., et al. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: Is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?. Int J Gynecol Cancer 16 (2006) 277-282
26. Strauss H.G., Kuhnt T., Laban C., et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 178 (2002) 378-385